Calcium Carbonate

證據等級: L5

預測適應症: 0 個

Calcium Carbonate: Repurposing Evaluation Pending Data Remediation

One-Sentence Summary

Calcium Carbonate (DrugBank ID: DB06724) is a well-characterised inorganic compound with broad pharmaceutical use, though no approved indications were retrieved from the current regulatory dataset. The TxGNN model did not generate any repurposing predictions for this compound in the current analysis cycle, and two blocking or high-severity data gaps remain unresolved. A full repurposing evaluation cannot be completed until these gaps are remediated.

Quick Overview

Item	Content
Original Indication	Not available in current dataset
Predicted New Indication	No predictions generated in current cycle
TxGNN Prediction Score	N/A
Evidence Level	N/A
South Africa Market Status	Not marketed
Number of SAHPRA Registrations	0
Recommended Decision	Hold

Safety Considerations

Please refer to the SAHPRA-approved Professional Information (PI) for safety information. Report adverse drug reactions to SAHPRA.

Conclusion and Next Steps

Decision: Hold

Rationale: The TxGNN pipeline returned no repurposing predictions for Calcium Carbonate in this cycle, and two unresolved data gaps — a blocking gap in safety/PI data and a high-severity gap in mechanism of action — prevent meaningful safety or mechanistic evaluation. Additionally, no SAHPRA registrations were identified in the dataset, making a South African market context assessment impossible without further investigation.

To proceed, the following is needed:

Remediate DG001 (Blocking): Obtain the SAHPRA-approved Professional Information (PI) by downloading and parsing the official PI PDF from the SAHPRA website; this is required before any safety screening can proceed
Remediate DG002 (High): Query the DrugBank API for DB06724 to retrieve mechanism of action data; this is required to support mechanistic plausibility analysis
Investigate absent predictions: Verify that DB06724 is correctly represented as a node in the TxGNN knowledge graph and that drug–disease edges are present; if the node is missing or disconnected, re-run the KG mapping and prediction pipeline
Confirm SAHPRA registration status: Calcium Carbonate is a widely used compound — confirm whether South African registrations exist under a different DrugBank entry, product name, or combination product, and update total_licenses accordingly
Re-run full pipeline after all blocking and high-severity data gaps are resolved to generate a complete Evidence Pack (v5+)

⚠️ Disclaimer: This report is intended for research reference only and does not constitute medical advice. All drug repurposing candidates require clinical validation before any therapeutic application. Please report any adverse drug reactions to SAHPRA.

Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.